We combine cutting-edge AI technology with expert oversight to streamline the redaction process while ensuring patient privacy.
Global regulatory expertise
Leverage our experienced team to navigate complex regulations across global jurisdictions.
Custom risk assessments
We utilize risk-based questionnaires and multi-system assessments to optimize the balance between utility and risk.
Proven Track Record
With over 15 million report pages redacted and 40+ sponsors annually, we deliver trusted results.
Enhance engagement, compliance, and trust
Veristat delivers customized solutions to meet evolving global transparency requirements. From accurate clinical trial postings to AI-powered data anonymization, we help you navigate the complex regulatory landscape with precision and ease. By incorporating patient-centric approaches and leveraging advanced technology, we ensure compliance while enhancing trust and engagement with all stakeholders.
Precision transparency for evolving regulations
AI-powered anonymization & redaction solutions
Our advanced, AI-driven anonymization and redaction services combine TrialAssure’s purpose-built technology with expert review to protect sensitive patient data while ensuring compliance with rigorous regulatory standards.
Designed to handle the complexities of modern clinical trials, our adaptive and precise anonymization and redaction solutions empower you to focus on advancing groundbreaking medical research without compromising confidentiality.
Our Offering
Cutting-Edge Data Anonymization
Our AI-powered data anonymization services, powered by TrialAssure, ensure compliance with EMA, FDA, and HC guidelines, processing over 15 million pages.
Accurate Clinical Trial Postings
Proven methodologies for successful trial postings across global registries, including clinicalTrials.gov and CTIS.
Tailored risk thresholds
We help clients optimize their approach with customized thresholds for populations, rare diseases, and more.
Expert consultation services
Our global team provides comprehensive guidance, from policy creation to expedited disclosure processes.
Regulatory insight
As key opinion leaders, our experts regularly speak at major transparency and disclosure events worldwide.
Senior Director, Regulatory Operations and Clinical Disclosure
Evan’s experience in the pharmaceutical industry includes drugs, biologics, and medical devices. He has worked for both service providers and in industry over the past 18 years. In his current role, Evan leads a global team supporting Veristat’s clients in meeting regulatory requirements for the disclosure of clinical data.
Anaya Rehman
Senior Transparency Specialist
Anaya Rehman has more than 10 years of experience in healthcare, academic research, and the pharma industry. She provides technical leadership and subject matter expertise for the clinical trial transparency and disclosure team at Veristat. She works with clinical trial sponsors to meet the stringent requirements of regulations such as EMA Policy 0070, Health Canada Public Release of Clinical Information and European Union Clinical Trial Regulation 536/2014.
Honz Slipka
Senior Transparency Specialist
With a research background in neuroscience, and experience in health information technology, Honz has a thorough understanding of data analysis, regulatory standards, and best practices in the field of clinical data privacy.
Michele Andrush
Associate Director of Disclosure Services
Michele specializes in working with Veristat’s valued partners to improve all Disclosure services. She is passionate about helping sponsors exceed new compliance regulations and benefit from transparency in the drug development process.
Your Partner in Transparency
We combine decades of expertise with cutting-edge technology to deliver innovative solutions for clinical trial transparency and disclosure. Our services ensure compliance with evolving regulatory requirements while fostering trust and collaboration in drug development.
85+
EMA and Health Canada dossiers published, helping sponsors navigate complex global submissions
2.7m+
regulatory submission pages processed with precision and compliance since 2022
Planning for a Successful EMA Policy 0070 Submission
Read More →
Transparency and Disclosure Fact Sheet
Download →
EU CTIS: Europe’s New Clinical Trial Information System
Learn More →
Learn More →
Make your data public without putting privacy at risk.
Clinical transparency requires a careful balance between disclosure, data utility, and protection. Veristat combines regulatory expertise, advanced anonymization technology, and expert review to prepare clinical data for public disclosure while protecting patient privacy and confidential information across global requirements.
Clinical trial transparency and disclosure refer to the processes of sharing trial data to meet regulatory requirements, foster trust, and enhance engagement.
We provide tailored solutions, including data anonymization, clinical trial postings, and plain language documents, to ensure compliance with global standards.
Sponsors must navigate a range of regional and international disclosure requirements, including registering trials and posting results (such as on ClinicalTrials.gov), redacting and anonymizing documents to protect patient privacy, and complying with frameworks like the EU's Policy 0070 for clinical data transparency.
Redaction and anonymization remove or mask personal and commercially confidential information from clinical trial documents before they're made public, allowing sponsors to meet disclosure requirements without exposing patient identities or proprietary business information (CCI/CBI).
